DK290588A - PURE-INHIBITED PEPTID - Google Patents

PURE-INHIBITED PEPTID

Info

Publication number
DK290588A
DK290588A DK290588A DK290588A DK290588A DK 290588 A DK290588 A DK 290588A DK 290588 A DK290588 A DK 290588A DK 290588 A DK290588 A DK 290588A DK 290588 A DK290588 A DK 290588A
Authority
DK
Denmark
Prior art keywords
peptid
inhibited
pure
inhibited peptid
Prior art date
Application number
DK290588A
Other languages
Danish (da)
Other versions
DK290588D0 (en
Inventor
Heinrich J Schostarez
Jr Jackson B Hester
Tomi K Sawyer
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of DK290588A publication Critical patent/DK290588A/en
Publication of DK290588D0 publication Critical patent/DK290588D0/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/02—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link
    • C07K5/0227—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing at least one abnormal peptide link containing the (partial) peptide sequence -Phe-His-NH-(X)2-C(=0)-, e.g. Renin-inhibitors with n = 2 - 6; for n > 6 see C07K5/06 - C07K5/10
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
DK290588A 1986-09-30 1988-05-27 PURE-INHIBITED PEPTID DK290588D0 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US91349086A 1986-09-30 1986-09-30
US92583086A 1986-10-30 1986-10-30
US707987A 1987-01-27 1987-01-27
PCT/US1987/002264 WO1988002374A2 (en) 1986-09-30 1987-09-10 Renin inhibitory peptides having novel c-terminal moieties

Publications (2)

Publication Number Publication Date
DK290588A true DK290588A (en) 1988-05-27
DK290588D0 DK290588D0 (en) 1988-05-27

Family

ID=27358265

Family Applications (1)

Application Number Title Priority Date Filing Date
DK290588A DK290588D0 (en) 1986-09-30 1988-05-27 PURE-INHIBITED PEPTID

Country Status (5)

Country Link
EP (1) EP0321497A1 (en)
JP (1) JPH02500025A (en)
AU (1) AU7968687A (en)
DK (1) DK290588D0 (en)
WO (1) WO1988002374A2 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU619222B2 (en) * 1987-10-21 1992-01-23 Upjohn Company, The Renin inhibitors containing a (1-amino-2-hydroxy-2- heterocyclic)ethyl moiety
DE3814325A1 (en) * 1988-04-28 1989-11-09 Merck Patent Gmbh AMINOSAEUREDERIVATE
SE8802428D0 (en) * 1988-06-28 1988-06-28 Haessle Ab NEW COMPOUNDS
WO1990002137A1 (en) * 1988-08-19 1990-03-08 The Upjohn Company Renin inhibitory peptides containing suleptanic acid or derivatives thereof
US5164388A (en) * 1988-10-19 1992-11-17 Abbott Laboratories Heterocyclic peptide renin inhibitors
US5554783A (en) * 1989-05-23 1996-09-10 Abbott Laboratories Retroviral protease inhibiting compounds
US5354866A (en) * 1989-05-23 1994-10-11 Abbott Laboratories Retroviral protease inhibiting compounds
US5539122A (en) * 1989-05-23 1996-07-23 Abbott Laboratories Retroviral protease inhibiting compounds
US5643878A (en) * 1991-09-12 1997-07-01 Ciba-Geigy Corporation 5-amino-4-hydroxyhexanoic acid derivatives
TW217410B (en) * 1992-04-01 1993-12-11 Ciba Geigy
DE674513T1 (en) * 1992-12-29 1996-01-18 Abbott Lab INHIBITORS OF THE RETROVIRAL PROTEASE.
US5786500A (en) * 1993-10-22 1998-07-28 Abbott Laboratories Process for the preparation of a substituted 2.5-diamino-3-hydroxyhexane
US5491253A (en) * 1993-10-22 1996-02-13 Abbott Laboratories Process for the preparation of a substituted 2,5-diamino-3-hydroxyhexane
ES2180600T3 (en) * 1994-10-19 2003-02-16 Novartis Ag ETERES OF ISOSTEROS SUBSTRATO DE ASPARTATO PROTEASA ANTIVIRALES.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4595677A (en) * 1982-12-03 1986-06-17 Ciba-Geigy Corporation Substituted tetrapeptides
EP0163237A3 (en) * 1984-05-29 1988-04-27 Merck & Co. Inc. Di- and tri-peptidal renin inhibitors
EP0486478A3 (en) * 1984-08-06 1992-08-12 The Upjohn Company Renin-inhibiting peptides

Also Published As

Publication number Publication date
DK290588D0 (en) 1988-05-27
JPH02500025A (en) 1990-01-11
WO1988002374A2 (en) 1988-04-07
EP0321497A1 (en) 1989-06-28
AU7968687A (en) 1988-04-21
WO1988002374A3 (en) 1988-08-11

Similar Documents

Publication Publication Date Title
AT399804B (en) SPORTSHOE
DK85987D0 (en) CLAIM
DK290588A (en) PURE-INHIBITED PEPTID
DK354487D0 (en) ONCOGEN-RELATED PEPTIDES
DK531986D0 (en) PEPTIDES
ATA246886A (en) SHAFTSYSTEM
ATA48386A (en) CRANEWAY
MC1830A1 (en) PEPTIDES
ATA179487A (en) MAISHAECKSLER
DK540087D0 (en) PEPTID PREPARATION
DK376187D0 (en) PEPTIDES
DK91686D0 (en) PEPTIDES
DK91586D0 (en) PEPTIDES
DK434986D0 (en) PEPTIDES
DK435086D0 (en) PEPTIDES
BR6600467U (en) ANTIASSALT
BR6601281U (en) AEROMODEL
BR6600239U (en) CONDUCTIVIMETER
BR6600356U (en) DADOTENIS
BR6600378U (en) SCHEDULE-CALENDAR
BR6600088U (en) MINI-DRINKING
BR6600495U (en) MICRO-FRAGMENTADORA
BR6600559U (en) MINI-TRIPE
BR6600838U (en) SALER
BR6601341U (en) BILLBOOK

Legal Events

Date Code Title Description
ATS Application withdrawn